brolucizumab
Rh-positive blood type
tislelizumab
counterimmune
olaratumab
certolizumab
gevokizumab
abagovomab
pathoantigen
ozoralizumab
ravulizumab
lenzilumab
Rh positive
preimmune
Duffy antigen
immunoabsorbent
talizumab
rhabdomyoblastic
bezlotoxumab
perakizumab
belimumab
immunovaccine
interhombomeric
immunoagglutination
agonistic monoclonal antibody
immunospecific
soravtansine
fontolizumab
rheopectic
Rhesus factor
immunodeposit
-axo-
antigenically
vepalimomab
immunonaive
idiospecific
rhopalid
immunome
conatumumab
isoantibody
-o-
antiglucagon
immunize
inflammasome
rheotactic
immunoprevention
inflammosuppression
histocompatibility antigen
countercorrelated